GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

sviceucin   Click here for help

GtoPdb Ligand ID: 14264

Synonyms: SSV-2083
Compound class: Peptide
Comment: Sviceucin is an antimicrobial lasso peptide produced by Streptomyces sviceus [2]. Note that the structure shown here matches the CAS-assigned structure.
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@H](C)[C@@]1([H])C(=O)N[C@@H](CSSC[C@@]2([H])C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@]3([H])CC(=O)N[C@@]([H])(CSSC[C@@]([H])(C(=O)NCC(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC6=CC=CC=C6)NC3=O)C(=O)N[C@@H]([C@H](C)C)C(=O)N[C@@H](CC7=CNC8=C7C=CC=C8)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N2)C(=O)N[C@@H](C(C)C)C(=O)O
Isomeric SMILES C(C=1C=2C(NC1)=CC=CC2)[C@H]3C(=O)N[C@@]([C@H](CC)C)(C(=O)N[C@H](C(N[C@@H](C(C)C)C(O)=O)=O)CSSC[C@]4(C(=O)N[C@@]([C@@H](C)O)(C(=O)N[C@@]5(C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@](C(=O)NCC(=O)N[C@@]([C@@H](C)O)(C(=O)N[C@@H](C)C(=O)N3)[H])(CSSC[C@@](C(=O)N[C@@H]([C@H](C)C)C(=O)N[C@@H](CC=7C=8C(NC7)=CC=CC8)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N4)(NC(=O)C5)[H])[H])[H])[H])[H])[H]
InChI InChI=1S/C92H126N22O26S4/c1-12-45(8)74-89(136)109-65(86(133)112-73(44(6)7)92(139)140)41-144-143-40-64-87(134)114-76(48(11)116)91(138)107-60-30-66(117)101-63(85(132)111-72(43(4)5)88(135)106-58(28-50-32-93-54-24-18-16-22-52(50)54)79(126)96-34-67(118)95-35-68(119)100-61(31-71(122)123)83(130)108-64)39-142-141-38-62(102-69(120)36-97-78(125)56(26-42(2)3)104-81(128)57(105-82(60)129)27-49-20-14-13-15-21-49)80(127)98-37-70(121)110-75(47(10)115)90(137)99-46(9)77(124)103-59(84(131)113-74)29-51-33-94-55-25-19-17-23-53(51)55/h13-25,32-33,42-48,56-65,72-76,93-94,115-116H,12,26-31,34-41H2,1-11H3,(H,95,118)(H,96,126)(H,97,125)(H,98,127)(H,99,137)(H,100,119)(H,101,117)(H,102,120)(H,103,124)(H,104,128)(H,105,129)(H,106,135)(H,107,138)(H,108,130)(H,109,136)(H,110,121)(H,111,132)(H,112,133)(H,113,131)(H,114,134)(H,122,123)(H,139,140)/t45-,46-,47+,48+,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,72-,73-,74-,75-,76-/m0/s1
InChI Key SLPRSALLYDJDLY-CJSAPLTJSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Boudrioua A, Baëtz B, Desmadril S, Goulard C, Groo AC, Lombard C, Gueulle S, Marugan M, Malzert-Fréon A, Hartke A et al.. (2025)
Lasso peptides sviceucin and siamycin I exhibit anti-virulence activity and restore vancomycin effectiveness in vancomycin-resistant pathogens.
iScience, 28 (3): 111922. [PMID:40034853]
2. Li Y, Ducasse R, Zirah S, Blond A, Goulard C, Lescop E, Giraud C, Hartke A, Guittet E, Pernodet JL et al.. (2015)
Characterization of Sviceucin from Streptomyces Provides Insight into Enzyme Exchangeability and Disulfide Bond Formation in Lasso Peptides.
ACS Chem Biol, 10 (11): 2641-9. [PMID:26343290]